PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study - Tchao, N; Sarkar, N; Hu, X; Zhang, R; Milmont, C; Shi Jin, Y; Chow, V; Kroenke, M; Gorski, K; Furie, R; Alan, K; Stanley, C (Lupus science & medicine, 2022)
Keywords: Friday 07 October 2022 from 13:00 to 14:10; Lymphocytes